# [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

> **NCT00588185** · NA · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 300 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone

## Key facts

- **NCT ID:** NCT00588185
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2003-02
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00588185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00588185, "[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00588185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*